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Background Prenatal Care is a critical aspect of women’s health and current literature
shows adequate care significantly reduces risk of adverse outcomes. With scientific
advancement, the initial prenatal visit is increasingly tasked with more objectives that
leave providers with barriers to provide appropriate and adequate care. Purpose The aim
of this survey study was to determine clinical practices of the initial prenatal visit –
regarding history taking, counseling, lab work and screening prior to the onset of COVID19 Pandemic. Methods A one-time anonymous provider survey was distributed
electronically to all obstetrics providers in the Tampa Bay Region in Florida. Descriptive
statistics and bivariate analyses were performed for data analysis. Results A total of 67
responses were completed, and 58 responses analyzed after vetting for greater than 75%
completion. Providers reported the initial visit most commonly occurring in the 1st
trimester, and 90.2% reported the initial visit was completed via in-office visits. One
provider reported completing this visit via nursing phone call. 32.5% of providers
allocated 30-minutes and 34.1% reported allocating 45-minutes for an office visit. 50% of
providers felt there were able to appropriately counsel patients in visits that lasted up to 1
hour. All providers reported collecting a patient’s history themselves for the majority of
topics (90% or more). Discussion Providers reported the initial prenatal visit occurring
most commonly in the 1st trimester as an in-office visit. Providers utilized routine blood
work, and genetic screening per guidelines. Medical doctors reported the lowest rates of
direct discussion and review of prenatal counseling topics when compared to mid-level
practitioners. Given the onset and ongoing COVID-2019 pandemic since this survey study
was completed, future studies should see how the implementation of telehealth medicine
has impacted practices.

Background | Prenatal care is a necessary and critical
aspect of healthcare for women for prenatal education
and early risk stratification and risk reduction in
pregnancy. The American College of Obstetricians
and Gynecologists (ACOG) recommends that
pregnant women see their prenatal care provider at a
minimum of every 4 weeks until 28 weeks' gestation,
then every 2 weeks until 36 weeks’ gestation and every
week until delivery. The purpose is to record a
complete review of the patient's medical history and to
offer the recommended counseling during the initial
prenatal visit.1
It has been established that women who receive
prenatal care have an increased likelihood for better
maternal and infant outcomes.1 The earlier in
pregnancy a woman enters prenatal care, and the more
visits attended, is inversely associated with maternal

and fetal outcomes, such as preterm delivery, low term
birth weight and neonatal death.2-4
However, with scientific advancement, there are an
increasing number of topics, laboratory genetic
screening and testing to counsel and discuss with
patients during the prenatal period that are
recommended by American Academy of Pediatrics
(AAP) and ACOG guidelines. Despite these
guidelines, research shows there is an increase in
adverse pregnancy related outcomes, including
increased rates of low-birth-weight infants.5 These
statistics lead one to ask why. Review of the literature
shows there is currently limited data about the ability
of providers to cover all topics recommended in these
guidelines. Furthermore, there is currently limited data
about current in-office clinical practices and protocols
to manage the first prenatal visit with these guidelines
in place.
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With the Covid-19 pandemic OB practitioners are
evaluating how they provide OB care, including
adding telehealth visits. We wanted to understand
how providers are prioritizing the information they
need to gather, and the topics they need to review with
their patients, especially at the initial prenatal visit
(IPV). Our aim with this survey was to determine what
was covered at the initial prenatal visit, including
history taking, counseling, screening and laboratory
testing.
Methods | A one-time anonymous provider survey
was distributed electronically via Qualtrics survey
software. A listserv of all obstetrics providers that
deliver at Tampa General Hospital, as well as a
provider listserv created from a publicly available list
of medical providers (OBGYNs, NPs, and CNMs
licensed in Florida) from the Florida Board of
Medicine and Board of Nursing were utilized for
distribution. In total 764 provider email addresses
were gathered. 1 initial survey invitation was
distributed and then 3 subsequent reminder emails
were sent every 2 weeks. This project was reviewed
and approved by the Institutional Review Board at the
University of South Florida.
Provider demographics including, age, gender,
number of years in clinical practice, ethnicity as well
as provider type, and primary medical specialty were
collected. Providers’ opinions regarding their ability
to appropriately counsel, as well as the need to have
patients return for a second prenatal visit to complete
counseling and discussion was asked. Providers were
asked the frequency at which they refer patients to
genetic counselors. Lastly, it was asked if providers
had implemented a structured list of items to be
covered in their office practice during the initial
prenatal visit.
To understand current clinical practices, we asked who
was held responsible for gathering the patient’s
pertinent history taking, and if this was reviewed by
the provider (Nurse Practitioner, Certified Nurse
Midwife, or Physician) versus another healthcare
personnel (Medical Assistant, Registered nurse, other)
or if pertinent history was not routinely discussed at
the initial prenatal visit Pertinent history taking
included prior medical and surgical history, current
medications, allergies, family, social, obstetric and
gynecological history as well as recent travel exposure
and familial ethnicity. Likewise, providers were asked
Mode of Initial Office Visit and Perception of
Adequate Counseling. Providers predominantly
reported seeing patients for their first prenatal visit
during the 1st trimester. As patients had increasing
gestational age, providers reported a smaller
percentage of patients presenting for their 1st prenatal

who discussed and reviewed the introduction to the
office practice, and who provided counseling on
exercise recommendations, dental care, nutrition and
diet, fevers/illnesses and safe medications,
environmental
exposures,
travel
limitation,
miscarriage precautions, prenatal vitamins, weight
gain and recommended genetic screening during
pregnancy.
To describe current testing trends, providers were
asked to indicate whether they “always order”,
“sometimes order based on risk factors” or “never or
rarely ordered” the following at the initial visit: blood
type and Rh factor, anemia screen, rubella titers,
varicella titer, syphilis screen, gonorrhea and
chlamydia screen, urine culture, HIV screen, hepatitis
B surface antigen, and Pap Smear. To describe current
genetic screening and testing trends, providers were
asked whether they offered a dating ultrasound, first
trimester screen bloodwork and nuchal translucency
ultrasound, cell free DNA, Quad Screen or AFP and
Expanded Carrier Panel Screening to “all patients,”
“only if considered a “high risk pregnancy,” or not
offered in their practice.
All descriptive statistics were calculated via Microsoft
Excel 2020 and chi square analysis was performed via
the Qualtrics Survey Software © 2020.
Results | A total of 67 responded out of a possible 764;
this total was calculated after excluding invalid emails,
and emails that bounced back per the Qualtrics Survey
Software System. After further vetting responses for
those with greater than or equal to 75% completion, a
total of 58 responses were analyzed for clinical
practices.
The majority of our providers identified as medical
doctors (61%), identified as female (85.2%) and were
on average 47 years old (+/- 12.7) and on average in
clinical practice 18 years (+/- 13.3 yrs.). Most
providers identified as Caucasian/white (68.3%), with
14.6% identifying as black/African American and just
under 10% identifying as multiracial. Providers
reported providing care to ethnically diverse patient
populations
from
varying
socioeconomic
backgrounds. Approximately one quarter of providers
(24.4%) have not implemented a structured list of
items to be covered at this visit. (Table 1)
visit. 90.2% reported the initial visit was completed
via in office visits; however, a small minority (2.4%)
reported completing this visit via nursing phone call.
100% of all patient history taking and prenatal topics
were reported as discussed via nursing phone calls.
One third of all providers allocated 30-minute office
visit and another third reported allocating 45-minute
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office visit (32.5% and 34.1%, respectively) for an
office visit, with only 20.0% reporting over an hour
time slot for the initial prenatal visit.
At most 50% of providers reported feeling they
appropriately counseled patients regardless of visit
time length up to a 1 hour for 76-100% of visits, and
only in visits reported as 1 hour or greater did 87.5%
of all providers feel they appropriately counseled
patients. Not even one third of medical doctors

(29.2%) felt they could appropriately counsel patients
the majority of the time during their allotted time slots,
but 50% of certified midwives felt they could
complete the counseling in over 76-100% of visits.
Yet, 90% of all providers reported only bringing
patients back for a second visit to complete the initial
prenatal visit up to 25% of the time.

Table 1. Provider demographics
Provider Demographics
Responses N (%)
Gender
Female
46 (85.2)
Male
8 (14.8)
Age [mean (SD)]
47 (12.7)
Clinical Practice-Years [mean (SD)]
18 (13.3)
Type of Provider
Medical Provider (MD/DO)
29(60.4)
Nurse Practitioner
4 (4)
Certified Nurse Midwife
4 (8.3)
Medical Assistant
0 (0)
Other (1 MFM, 2 Obstetric Hospitalists)
3 (6.3)
Race/Ethnicity*
White/Caucasian
37 (74)
Native Hawaiian/Other Pacific Islander
0 (0)
Hispanic/Latin
4 (8.0)
Black/African American
7 (14.0)
Asian
2 (4)
American Indian/Alaska Native
0 (0)
Provider Practice Demographics
% Range
% Ethnicity of Patient Population
White/Caucasian
0-100
Native Hawaiian/Other Pacific Islander
0-5
Hispanic/Latin
0-44
Black/African American
0-60
Asian
0-15
American Indian/Alaska Native
0-5
% Insurance Breakdown of Patient Population
Private Insurance (including HMO, IPO, etc)
0-95
Medicaid/Medicare
0-100
Tricare
0-35
Uninsured or Self Pay
0-100
* Multi-response variable, percentage may add up to more than 100%
In office history taking and counseling practices. All
providers reported collecting a patient’s history
themselves for the majority of topics as greater than
90%; however, allergies (70.7%), current medications
(85.4%), recent travel exposure (39.0%), and familial
ethnicity (70.7%) were reported less. When evaluated
by provider type, although not statistically significant,
medical doctors reported discussing counseling topics
much less themselves, than certified nurse midwives
and the nurse practitioner, with at most 70.8% of

medical doctors reported discussing nutrition and diet
and all other topics reported as less. (Table 2)
All providers reported routinely ordering most blood
tests during the initial prenatal visit; however, the least
reported blood test was varicella with 30% ordering at
all times, otherwise on a risk-based assessment and
70% ordered a pap smear at all times regardless of if
up to date or not. When evaluating by provider types,
we noted anemia screening, gonorrhea and chlamydia
DELGADO ET AL
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(p = <0.001), syphilis and HIV screening were much
more likely to be ordered at in all cases compared to
only with elevated risk assessment.
Table 2. In office reported discussions.
History/Discussion Topic
Prior Medical History
Prior Surgical History
Current Medications
Allergies
Family History (including bleeding disorders,
developmental delay, and cancer history)
Social History (including current partner, sexual
practices, alcohol and substance use)
Obstetric History
Gynecological History
Recent Travel Exposure
Family Ethnicity
Introduction to Obstetric Practice (Scheduling,
numbers, etc)
Personal Provider Introduction
Exercise Recommendations
Dental Care
Nutrition and Diet
Fevers, Illness, and Safe Medications to Take
During These Times
Environmental Exposures
Travel Limitations
Miscarriage Precautions
Prenatal Vitamins, Supplements
Recommended Genetic Screening
Weight Gain
All providers reported discussing genetic screening
with patients themselves. At most, 63.4% of providers
reported offering a First Trimester Screen with Nuchal
Translucency ultrasound, while less offered a dating
ultrasound (41.5%) to all patients. Similarly, 63.4%
recommend Quad Screen or AFP to all patients. Cell
free DNA or NIPT was the most ordered in
circumstances of patients classified as having a “high
risk” pregnancy (70.7%). Lastly, 15% of all providers
report not offering expanded carrier panel screening.

Identified Primary Provider
Medical Doctor
Mid-Level Provider
N (%)
N (%)
24 (96)
13 (100)
24 (96)
13 (100)
19 (76)
13 (100)
15 (60)
13 (100)
22 (88)
11 (84.6)

P-value
0.720
0.720
0.105
0.146
0.354

21 (84)

13 (100)

0.606

23 (92)
23 (92)
8 (32)
15 (60)
17 (68)

12 (92.3)
13 (100)
6 (54.6)
11 (84.6)
13 (100)

0.510
0.879
0.174
0.422
0.041

22 (88)
17 (68)
11 (44)
17 (70.8)
17 (68)

13 (100)
12 (100)
8 (100)
13 (100)
10 (83.3)

0.715
0.123
0.144
0.084
0.431

16 (66.7)
14 (56)
15 (60)
19 (76)
25 (100)
21 (84)

11 (91.7)
9 (100)
8 (100)
12 (92.3)
13 (100)
12 (100)

0.659
0.242
0.144
0.320
1.0
0.525

Sixty percent of medical doctors ordered a dating
ultrasound, while only 15.4% of mid-level
practitioners order this routinely for all patients (p =
0.021). Medical doctors and mid-level practitioners
both reported ordering a quad screen for all patients
about two thirds of the time (64% and 69.2%,
respectively. 84% of medical doctors reported cell free
DNA test ordering when based on risk factors, and
mid-level practitioners reported slightly less at 61.5%;
however, mid-level practitioners (38.5%) reported
ordering cell free DNA for all patients twice what
medical doctors reported (16%; p = <0.001). (Table 3)

DELGADO ET AL

https://digitalcommons.unf.edu/fphr/vol18/iss1/4

24
4

Delgado et al.: Provider Perception and Office Practices of the Initial Prenatal

Table 3. Reported screening and testing performed during the initial prenatal visit.

Bloodwork Screening and Testing
Blood Type and RH Factor
Anemia Screen
Rubella SG
Varicella
Syphilis Screen
Gonorrhea and Chlamydia Screen
Urine Culture
HIV Screen
Hepatitis B Surface Antigen
PAP Smear
Genetic Screening and Testing
Dating Ultrasound
First Trimester Bloodwork and NT Ultrasound
Cell Free DNA or NIPT Test
Quad Screen or AFP
Expanded Carrier Panel Screening
Discussion | Providers reported the initial prenatal
visit occurred during the first trimester during an inperson office visit. This is a promising result as prior
data show there is a relationship between adequate
early prenatal care and decreased risks of adverse
maternal and neonatal outcomes.2-6
To address the considerable number of health-related
topics and counseling topics to be addressed, providers
utilized differing allotments of office visit time, with
over two thirds taking more than 30 minutes. Prior
work by Dyer, et. al (2018)7 found in audio recordings
of initial prenatal visits providers often did not discuss
and counsel patients on multiple topics, with the most
reported being about the scope of the practice,
followed by initial history and physical (83%
occurrence) as well as routine blood work (97%
occurrence). Compared to the current study, multiple
similarities were observed as medical doctors tended
to also focus on history, routine blood work, with less
of a focus on direct educational counseling (like on
diet, exercise recommendations, etc.). Medical doctors
reported the lowest rates of direct discussion and
review of prenatal counseling topics when compared
to mid-level practitioners, as well as reported the felt
least amount of appropriate counseling and only half
of providers reported they felt they were able to
appropriately address and counsel patients in the
majority of their visits. This may be due to a plethora
of reasons, including increasing complexity of patients
seen, prioritization of competing topics for discussion
with emphasis on medical and surgical history and the
implementation of other modes of information
distribution in office – like in office staff counseling

Identified Primary Provider that “Always Orders” /
“Sometimes Based on Risk Factors”
Medical Doctor
Mid-Level Provider
P-value
N (%)
N (%)
25 (100) / 0 (0)
13 (100) / 0 (0)
1.00
24 (96) / 1 (4)
12 (100) / 0 (0)
0.011
23 (92) / 2 (8)
11 (100) / 0 (0)
0.554
5 (20) / 11 (44)
7 (58.3) / 3 (25)
0.159
25 (100) / 0 (0)
13 (100) / 0 (0)
1.00
25 (100) / 0 (0)
11 (84.6) / 2 (15.4)
<0.001
24 (96) / 1 (4)
12 (92.3) / 1 (7.7)
0.8368
25 (100) / 0 (0)
13 (100) / 0 (0)
<0.001
25 (100) / 0 (0)
13 (100) / 0 (0)
1.00
20 (80) / 5 (20)
8 (61.5) / 4 (30.8)
0.219
15 (60) / 9 (36)
19 (76) / 5 (20)
4 (16) / 21 (84)
16 (64) / 9 (36)
13 (54.2) / 9 (37.5)

2 (15.4) / 10 (76.9)
6 (46.2) / 4 (30.8)
5 (38.5) / 8 (61.5)
9 (69.2) / 4 (30.8)
4 (30.8) / 7 (53.8)

0.021
0.205
<0.001
0.010
0.058

or handouts regarding recommendations for daily
nutrition and lifestyle recommendations. It was seen
the implementation of a nursing phone call in addition
to the in-office visit allowed all patient history taking
and prenatal topics to be addressed separate from the
initial in office visit acting as a potential solution;
however, given this was reported by 1 respondent we
limited in our ability to conclude the impact this has
on prenatal care and providers’ perceptions of their
ability to appropriately counsel patients.
In regards to genetic screening, several trends were
noted. Providers more often ordered a First Trimester
Screen with Nuchal Translucency than a dating
Ultrasound. Increasing patient requests for genetic
screening, as a result of direct-to-consumer
information expansion or due to efficient resource
utilization due to the limited number of ultrasound
visits and technicians available to perform these tasks
in a time appropriate manner, may explain these
trends. Furthermore, it was observed midlevel
providers ordered more cell free DNA testing for all
patients, compared to Medical doctors who more often
reported testing based on risk factors. All in all, the
majority of providers reported ordering genetic
screening – in line with prior work that found 90% of
healthcare workers offered genetic screening at the
prenatal visit.8
This study was limited in several ways. Given the low
response rate, the conclusions drawn may not be
applicable to the general population. Furthermore, this
study provides only insight from the provider, and not
the recipient (the patient). This may be creating a bias
DELGADO ET AL
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as even though providers reported high levels of
counseling, patients may feel their questions and
concerns are not being fully addressed within these
topics.
Implications for Public Health Practice |
In
conclusion, this survey aimed to describe clinical
practices of the initial prenatal visit – regarding history
taking, counseling, lab work and screening prior to the
onset of COVID-19 Pandemic. To our knowledge,
there are a lack of data regarding specific reported
practices – the main objective of this study. We saw
providers report the majority of initial visits during the
1st trimester, a time period deemed necessary to

minimize future risks during pregnancy, but at the
same time noted limited rates of direct discussion on
multiple important topics, compared to mid-level
practitioners. The implementation of a nursing phone
call presented itself as a potential and efficient way to
gather complete histories. Given the onset and
ongoing coronavirus pandemic since this survey study
was completed, future studies should look to see how
the implementation of telehealth medicine has
impacted providers’ practices regarding the initial
prenatal visit. Additionally, telecommunication
methods should be studied as routine for all initial
prenatal visits should be studied as it may be an
effective and efficient alternative method.
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